首页 > 市场调查报告书 > 製药

呼吸器

市场调查报告书

商品编码

1391916

支气管扩张药物市场：依药物类别、给药途径、配销通路及地区

Bronchiectasis Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2023年11月10日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2023年全球支气管扩张药物市场规模为3.348亿美元，2030年将达6.607亿美元，2023年至2030年复合年增长率为10.2%。

报告范围		报告详情
基准年	2022年	2023年市场规模	3.348 亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	10.20%	2030年市场规模预测	6.607 亿美元

图 1. 2023 年支气管扩张药物的全球市场占有率（按地区划分）

支气管扩张是一种肺部管道（气道）因损伤而变宽或成袋的疾病。排放肺部黏液变得困难，这可能导致频繁感染疾病。支气管扩张的主要症状是咳嗽，经常产生脓液或黏液。支气管扩张无法治愈，但可以透过治疗来控制。

支气管扩张药物对于控制支气管扩张的症状和併发症至关重要，支气管扩张是一种以支气管扩张为特征的慢性呼吸道疾病。这些药物旨在缓解慢性咳嗽、黏液分泌过多和反覆呼吸道感染疾病症状，同时减缓疾病的进展。支气管扩张药物包括支气管扩张剂、黏液清除药物、抗生素和发炎药物。这些药物的开发为改善患者预后和生活品质开闢了新的可能性。正在进行的支气管扩张研究正在探索新的治疗方法和标靶药物，为更有效的治疗和更好的疾病管理带来希望。

市场动态：

支气管扩张症盛行率的增加、治疗方案的进步以及对个人化医疗的日益关注预计将在预测期内推动全球支气管扩张药物市场的成长。此外，支持性的法规环境和市场参与者活性化的研发活动预计将在预测期内推动市场成长。

例如，2022年2月，生物技术公司Armata Pharmaceuticals, Inc.获得美国食品药物管理局（FDA）针对第二个适应症——非囊肿纤维化支气管扩张症的Optimized Lead，并宣布核准Armata的在临床实验（IND）申请开始其候选治疗药物 AP-PA02 的临床试验。

本研究的主要特点

该报告对全球支气管扩张药物市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球支气管扩张治疗药物市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
全球支气管扩张药物市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球支气管扩张药物市场的各种策略矩阵，将有助于相关人员做出决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 334.8 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	10.20%	2030 Value Projection:	US$ 660.7 Mn

Bronchiectasis is a condition where damage causes the tubes in your lungs (airways) to widen or develop pouches. It makes it hard to clear mucus out of your lungs and can cause frequent infections. Coughing a lot with pus and mucus is the main symptom of bronchiectasis. Bronchiectasis can't be cured but can be managed with treatment.

Bronchiectasis drugs are essential for managing the symptoms and complications of bronchiectasis, a chronic respiratory condition characterized by widening of the bronchial tubes. These drugs aim to alleviate symptoms like chronic cough, excessive mucus production, and recurrent respiratory infections while slowing down disease progression. Bronchiectasis drugs encompass bronchodilators, mucus-clearing agents, antibiotics, and anti-inflammatory medicine. Their development has opened new possibilities for improved patient outcomes and quality of life. Ongoing research in bronchiectasis explores novel therapeutic approaches and targeted medications, offering hope for more effective treatments and better disease management.

Market Dynamics:

The increasing prevalence of bronchiectasis, advancements in treatment options, and increasing focus on personalized medicine are anticipated to drive growth of the global bronchiectasis drugs market over the forecast period. Moreover, a supportive regulatory environment and increased research and developmental activities by market players is expected to drive market growth over the forecast period.

For instance, in February 2022, Armata Pharmaceuticals, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has cleared Armata's Investigational New Drug (IND) application to initiate a clinical trial of its optimized lead therapeutic candidate, AP-PA02, in a second indication, non-cystic fibrosis bronchiectasis.

Key features of the study:

This report provides in-depth analysis of the global bronchiectasis drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bronchiectasis drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, GlaxoSmithKline, Boehringer Ingelheim, Novartis, AstraZeneca, Sunovion Pharmaceuticals, Chiesi Farmaceutici
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bronchiectasis drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bronchiectasis drugs market

Detailed Segmentation:

Bronchiectasis drugs market, By Drug Class:
- Antibiotics
- Mucolytics
- Bronchodilators
- Anti-inflammatory agents
Bronchiectasis drugs market, By Route of Administration:
- Oral
- Inhalation
- Intravenous
Bronchiectasis drugs market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Bronchiectasis drugs market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles:
- Bayer
- GlaxoSmithKline
- Boehringer Ingelheim
- Novartis
- AstraZeneca
- Sunovion Pharmaceuticals
- Chiesi Farmaceutici

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Bronchiectasis Drugs, By Drug Class
- Market Bronchiectasis Drugs, By Route of Administration
- Market Bronchiectasis Drugs, By Distribution Channel
- Market Bronchiectasis Drugs, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Bronchiectasis
Increasing Awareness of the Disease
- Restraints
Limited Awareness and Underdiagnoses
Lack of Specific Treatment Guidelines
- Opportunities
Unmet Medical Needs
Emerging Markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Bronchiectasis Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Bronchiectasis Drugs Market , By Drug Class, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Mucolytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Bronchodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Anti-inflammatory agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Bronchiectasis Drugs Market , By Route of Administration, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Bronchiectasis Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

8. Bronchiectasis Drugs Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
China
Japan
India
South Korea
ASEAN
Australia
Rest of Middle East
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Bayer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sunovion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Chiesi Farmaceutici
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

支气管扩张药物市场：依药物类别、给药途径、配销通路及地区